Technology | September 12, 2011

Fujifilm’s Aspire HD Receives FDA Clearance

September 12, 2011 – Breast imaging facilities looking for increased diagnostic confidence in mammography screening can now benefit from the exceptional image quality of the Aspire HD full-field digital mammography (FFDM) system from Fujifilm Medical Systems U.S.A. Now U.S. Food and Drug Administration (FDA)-510(k) cleared, the Aspire HD provides image clarity that enables extraordinary detail of potential abnormalities that not only assists in more accurate and reliable diagnoses, but also results in enhanced clinician productivity.   

The exceptional image quality of the Aspire HD is made possible in part by the system’s unique proprietary detector that uses innovative dual-layer amorphous selenium (a-Se) and the first use of Fujifilm’s innovative direct optical switching (DOS) technology. This new technology combined with the company’s renowned 50-micron resolution provides facilities with the confidence they need for the detailed visualization that’s required in mammography.

The new DOS technology eliminates the use of thin film transistors (TFTs), which are currently used in typical FFDM detector systems. By eliminating the TFTs, this new technology creates a direct image transfer that results in a higher efficiency image capture.  This process produces images with less noise and the potential to reduce dose, while delivering the performance and reliability digital mammography users have come to expect from Fujifilm.

 Fujifilm has more than 8000 FFDM systems installed worldwide. The company was the first to bring computed radiography (CR)-based FFDM to the U.S. market in 2006 and has been successfully serving the needs of hospitals and imaging centers with the Aspire ClearView-CSm and the Aspire ClearView-1m, multi- and single-imaging plate systems with Image Intelligence, Fujifilm’s proprietary image processing technology.

 For more information: www.Aspire.fujimed.com

 

Related Content

Study Examines Characteristics of Mobile Mammography Patients
News | Mammography | October 18, 2017
Significant differences were found among women receiving mammography at a cancer center versus those visiting a mobile...
Machine Learning Identifies Breast Lesions Likely to Become Cancer
News | Artificial Intelligence | October 18, 2017
A machine learning tool can help identify which high-risk breast lesions are likely to become cancerous, according to a...
Volpara Solutions to Showcase VolparaEnterprise Live! at RSNA
News | Mammography | October 16, 2017
Volpara Solutions will introduce VolparaEnterprise Live!, a mammography quality control tool, at the 2016 Radiological...
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas
News | Breast Imaging | October 04, 2017
HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Kubtec Announces Expansion of 3-D Tomosynthesis Technology
News | Digital Radiography (DR) | October 04, 2017
October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA
The Siemens Acuson

The Siemens Acuson

Feature | Breast Imaging | October 04, 2017 | By Melinda Taschetta-Millane
According to a new Market Study Report,1 the automated breast ultrasound system (ABUS) market will see a 21 percent...
Overlay Init